Retired Officer Wins $79.8 Million After Defective Ethicon Stapler Causes Permanent Colostomy
After trial: Reduced on appeal; $79.8 million gross verdict.
Won by Alexander Law Group.
A jury awarded Florence Kuhlmann $79.8 million after an Ethicon PPH03 hemorrhoid stapler from a defective, recalled lot misfired during surgery, occluding her rectum and leaving her with a permanent colostomy.
What happened
Florence Kuhlmann spent her career as a San Jose police officer. In 2012, she underwent what was expected to be routine hemorrhoid surgery. The surgeon used an Ethicon PPH03 circular stapler, a device manufactured by Johnson & Johnson subsidiary Ethicon Endo-Surgery. The stapler misfired.
Instead of firing cleanly, the PPH03 stapled the upper portion of Kuhlmann's rectum to the lower portion, occluding the canal. Within days, her bowel had ruptured and she developed a serious infection. Surgeons performed a diverting colostomy to manage the damage. That colostomy became permanent.
Alexander Law Group, led by lead trial counsel Nina Shapirshteyn, filed suit in Alameda County Superior Court, alleging the stapler was defective and that Ethicon had known about the problem. At trial, the team proved that the PPH03 used on Kuhlmann came from a recalled lot. Insufficient lubrication inside the device created excessive internal friction, requiring more force to fire than the mechanism could safely deliver. Testing showed roughly one-third of staplers from the affected lots demonstrated the same force-to-fire defect. Multiple operating room personnel testified the device had been unusually difficult to fire, and incomplete staples recovered from Kuhlmann's body confirmed the malfunction.
Both Ethicon Endo-Surgery and its parent company JJHCS were found strictly liable. In December 2015, the jury awarded $9.8 million in compensatory damages and $70 million in punitive damages, a 7:1 ratio, for a total verdict of $79.8 million. Ethicon had declined a pre-trial settlement demand of $8 million.
Ethicon appealed the punitive award. In 2018, the California Court of Appeal, First District, reduced the punitive component to $19.6 million, applying a 2:1 cap and finding that any higher ratio would violate due process under the circumstances. Combined with the unchanged compensatory award, Kuhlmann's final judgment totaled $29.4 million.
Sources
This account is drawn from contemporaneous public reporting and the court record.
- 1.San Francisco Trial Lawyers Association, Trial Lawyer of the Year recognition, Kuhlmann v. Ethicon Endo-Surgery·Archived copy
- 2.Horvitz & Levy LLP - Court of Appeal Reduces $70M Punitive Award to $19.6M, Kuhlman v. Ethicon Endo-Surgery (2018 appellate decision summary)·Archived copy
- 3.Law360 - Calif. Woman Wins Almost $10M In Ethicon Stapler Suit
- 4.DrugWatch - Surgical Stapler Lawsuits: Verdicts and Settlements, Kuhlmann case cited·Archived copy
More proven verdicts from Alexander Law Group
All Alexander Law Group proven verdicts →Richard Alexander represented roughly 250 current and former IBM San Jose disk-drive plant workers and their families who alleged cancers and birth defects from chemical exposures, ultimately reaching a confidential settlement with IBM in June 2004 after a bellwether jury trial found for IBM.
Related product liability verdicts
Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.
C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.
As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.
After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.